Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8+ T cells ex vivo
- 91 Downloads
Recombinant Saccharomyces cerevisiae strains expressing HIV antigens have shown promising pre-clinical results. Probiotic S. cerevisiae strains naturally induce gut immunity; thus, genetically engineered probiotic strains could be used to stimulate immune responses against HIV in the mucosa. Probiotic strains have a higher rate of heterologous protein production, meaning higher antigen’s epitope expression levels per yeast cell. We expressed HIV-1 Gag protein in the probiotic yeasts’ surface, which was eagerly phagocytosed by and induced type 1 polarization of human monocyte-derived dendritic cells (DCs) from healthy donors in vitro. We further matured DCs derived from HIV-1+ donors with transformed yeasts and incubated them with autologous T cells. Only DCs matured with Gag-expressing probiotic strains were able to efficiently present antigen to CD8+ T cells and induced their clonal expansion. Our results show that genetically engineered probiotic S. cerevisiae strains are a promising vaccination strategy against HIV.
KeywordsHIV vaccine Saccharomyces cerevisiae Saccharomyces boulardii Probiotics Gag antigen
We thank Prof. Charles R. Rinaldo and Prof. Robbie B. Mailliard, both from Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, for the cells of the HIV+ patients from MACS cohort as well as helpful scientific discussions.
This work was supported by internal funding.
Compliance with ethical standards
Human subject research was approved by the University of Pittsburgh Institutional Review Board.
Conflict of interest
Bruno Douradinha is an inventor of the patent WO2018091637, partially based in this work. The other authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants’ samples were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. This article does not contain any studies with animals performed by any of the authors.
- Bax M, Kuijf ML, Heikema AP, van Rijs W, Bruijns SCM, García-Vallejo JJ, Crocker PR, Jacobs BC, van Vliet SJ, van Kooyk Y (2011) Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect Immun 79:2681–2689. https://doi.org/10.1128/IAI.00009-11 CrossRefGoogle Scholar
- Berk E, Muthuswamy R, Kalinski P (2012) Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs. Vaccine 30:6216–6224. https://doi.org/10.1016/j.pestbp.2011.02.012.Investigations CrossRefGoogle Scholar
- Cereda V, Vergati M, Huen NY, di Bari MG, Jochems C, Intrivici C, Gulley JL, Apelian D, Schlom J, Tsang KY (2011) Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine 29:4992–4999. https://doi.org/10.1016/j.vaccine.2011.04.101 CrossRefGoogle Scholar
- Dementhon K, El-Kirat-Chatel S, Noël T (2012) Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes. PLoS One 7. https://doi.org/10.1371/journal.pone.0032621
- Fiore-Gartland A, Manso BA, Friedrich DP, Gabriel EE, Finak G, Moodie Z, Hertz T, De Rosa SC, Frahm N, Gilbert PB, McElrath MJ (2016) Pooled-peptide epitope mapping strategies are efficient and highly sensitive: an evaluation of methods for identifying human T cell epitope specificities in large-scale HIV vaccine efficacy trials. PLoS One 11:e0147812. https://doi.org/10.1371/journal.pone.0147812 CrossRefGoogle Scholar
- Generoso SV, Viana ML, Santos RG, Arantes RME, Martins FS, Nicoli JR, MacHado JAN, Correia MITD, Cardoso VN (2011) Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii. Eur J Nutr 50:261–269. https://doi.org/10.1007/s00394-010-0134-7 CrossRefGoogle Scholar
- Generoso SV, Viana M, Santos R, Martins FS, Machado J a N, Arantes RME, Nicoli JR, Correia MITD, Cardoso VN (2010) Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192:477–484CrossRefGoogle Scholar
- Globeimmune (2016) Tarmogen platform. https://www.globeimmune.com/platform/technology/. Accessed 11 May 2016
- Ito T, Amakawa R, Inaba M, Hori T, Ota M, Nakamura K, Takebayashi M, Miyaji M, Yoshimura T, Inaba K, Fukuhara S (2004) Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 172:4253–4259. https://doi.org/10.4049/jimmunol.172.7.4253 CrossRefGoogle Scholar
- Kourelis A, Kotzamanidis C, Litopoulou-Tzanetaki E, Papaconstantinou J, Tzanetakis N, Yiangou M (2010) Immunostimulatory activity of potential probiotic yeast strains in the dorsal air pouch system and the gut mucosa. J Appl Microbiol 109:260–271. https://doi.org/10.1111/j.1365-2672.2009.04651.x Google Scholar
- Palma ML, Zamith-Miranda D, Martins FS, Bozza FA, Nimrichter L, Montero-Lomeli M, Marques ETA, Douradinha B (2015) Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? Appl Microbiol Biotechnol 99:6563–6570. https://doi.org/10.1007/s00253-015-6776-x CrossRefGoogle Scholar
- Reis VCB, Nicola AM, de Souza Oliveira Neto O, Batista VDF, de Moraes LMP, Torres FAG (2012) Genetic characterization and construction of an auxotrophic strain of Saccharomyces cerevisiae JP1, a Brazilian industrial yeast strain for bioethanol production. J Ind Microbiol Biotechnol 39:1673–1683Google Scholar
- Smith KN, Mailliard RB, Piazza PA, Fischer W, Korber BT, Fecek RJ, Ratner D, Gupta P, Mullins JI, Rinaldob CR (2016) Effective cytotoxic T lymphocyte targeting of persistent HIV-1 during antiretroviral therapy requires priming of naive CD8+ T cells. MBio 7:1–18. https://doi.org/10.1128/mBio.00473-16 CrossRefGoogle Scholar
- World Health Organization (2016) HIV/AIDS fact sheet. http://www.who.int/mediacentre/factsheets/fs360/en/. Accessed 11 Oct 2016
- Zamith-Miranda D, Palma ML, Matos GS, Schiebel J, Maya-Monteiro CM, Aronovich M, Bozza PT, Bozza FA, Nimrichter L, Montero-lomeli M, Marques ETA, Martins FS, Douradinha B (2016) Lipid droplet levels vary heterogeneously in response to simulated gastrointestinal stresses in different probiotic Saccharomyces cerevisiae strains. J Funct Foods 21:193–200CrossRefGoogle Scholar